Literature DB >> 20143654

Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria.

Ciro Romano, Ausilia Sellitto, Umberto De Fanis, Gaetano Esposito, Paola Arbo, Riccardo Giunta, Giacomo Lucivero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20143654     DOI： 10.1016/j.anai.2009.11.017

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  8 in total

Review 1.  Biologic agents in the treatment of urticaria.

Authors:  Allen P Kaplan
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

2.  Omalizumab for difficult-to-treat dermatological conditions: clinical and immunological features from a retrospective real-life experience.

Authors:  Ciro Romano; Ausilia Sellitto; Umberto De Fanis; Antonella Balestrieri; Alfonso Savoia; Salvatore Abbadessa; Corrado Astarita; Giacomo Lucivero
Journal:  Clin Drug Investig       Date:  2015-03       Impact factor: 2.859

Review 3.  Omalizumab: Anti-IgE therapy in allergy.

Authors:  Matthias Volkmar Kopp
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

4.  Omalizumab for chronic urticaria: a case series and overview of the literature.

Authors:  Ilya Ivyanskiy; Carsten Sand; Simon Francis Thomsen
Journal:  Case Rep Dermatol       Date:  2012-01-30

Review 5.  Role of biologics in intractable urticaria.

Authors:  Andrew Cooke; Adeeb Bulkhi; Thomas B Casale
Journal:  Biologics       Date:  2015-04-13

6.  Treatment of chronic spontaneous urticaria.

Authors:  Allen P Kaplan
Journal:  Allergy Asthma Immunol Res       Date:  2012-05-14       Impact factor: 5.764

7.  Omalizumab for chronic urticaria in Latin America.

Authors:  Paul Wilches; Paola Wilches; Juan Carlos Calderon; Annia Cherrez; Ivan Cherrez Ojeda
Journal:  World Allergy Organ J       Date:  2016-11-23       Impact factor: 4.084

8.  Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.

Authors:  Victor D Mandel; Mario B Guanti; Serena Liberati; Antongiulio Demonte; Giovanni Pellacani; Patrizia Pepe
Journal:  Dermatol Ther (Heidelb)       Date:  2018-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.